Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-24-002028
Filing Date
2024-10-07
Accepted
2024-10-07 11:37:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 6607
  Complete submission text file 0000315066-24-002028.txt   8478
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 (858) 263-4333
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91478 | Film No.: 241356669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)